Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.76
(0.0%)
CNY 8.76
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.79 Billion CNY | 0.08% |
| 2022 | 11.78 Billion CNY | 17.92% |
| 2021 | 9.99 Billion CNY | 18.47% |
| 2020 | 8.43 Billion CNY | 11.9% |
| 2019 | 7.53 Billion CNY | 24.17% |
| 2018 | 6.07 Billion CNY | 18.28% |
| 2017 | 5.13 Billion CNY | 46.16% |
| 2016 | 3.51 Billion CNY | 2.4% |
| 2015 | 3.42 Billion CNY | 3.47% |
| 2014 | 3.31 Billion CNY | 17.28% |
| 2013 | 2.82 Billion CNY | 27.03% |
| 2012 | 2.22 Billion CNY | 67.49% |
| 2011 | 1.32 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 12 Billion CNY | -0.11% |
| 2024 Q3 | 12.39 Billion CNY | 3.24% |
| 2024 Q1 | 12.02 Billion CNY | 1.93% |
| 2023 Q3 | 11.42 Billion CNY | -0.53% |
| 2023 Q4 | 11.79 Billion CNY | 3.26% |
| 2023 FY | 11.79 Billion CNY | 0.08% |
| 2023 Q1 | 11.34 Billion CNY | -3.68% |
| 2023 Q2 | 11.48 Billion CNY | 1.17% |
| 2022 Q4 | 11.78 Billion CNY | 9.57% |
| 2022 Q3 | 10.75 Billion CNY | 1.48% |
| 2022 Q2 | 10.59 Billion CNY | 0.79% |
| 2022 Q1 | 10.51 Billion CNY | 5.23% |
| 2022 FY | 11.78 Billion CNY | 17.92% |
| 2021 Q1 | 8.9 Billion CNY | 5.62% |
| 2021 Q2 | 9.06 Billion CNY | 1.8% |
| 2021 Q3 | 9.58 Billion CNY | 5.72% |
| 2021 Q4 | 9.99 Billion CNY | 4.23% |
| 2021 FY | 9.99 Billion CNY | 18.47% |
| 2020 Q4 | 8.43 Billion CNY | 0.71% |
| 2020 Q1 | 7.72 Billion CNY | 2.49% |
| 2020 Q2 | 7.97 Billion CNY | 3.28% |
| 2020 FY | 8.43 Billion CNY | 11.9% |
| 2020 Q3 | 8.37 Billion CNY | 4.97% |
| 2019 Q4 | 7.53 Billion CNY | 3.3% |
| 2019 FY | 7.53 Billion CNY | 24.17% |
| 2019 Q3 | 7.29 Billion CNY | 3.74% |
| 2019 Q2 | 7.03 Billion CNY | 5.55% |
| 2019 Q1 | 6.66 Billion CNY | 9.78% |
| 2018 FY | 6.07 Billion CNY | 18.28% |
| 2018 Q1 | 5.57 Billion CNY | 8.66% |
| 2018 Q2 | 5.53 Billion CNY | -0.81% |
| 2018 Q3 | 5.95 Billion CNY | 7.62% |
| 2018 Q4 | 6.07 Billion CNY | 1.96% |
| 2017 Q1 | 3.69 Billion CNY | 5.21% |
| 2017 Q2 | 4.54 Billion CNY | 23.12% |
| 2017 FY | 5.13 Billion CNY | 46.16% |
| 2017 Q4 | 5.13 Billion CNY | -3.42% |
| 2017 Q3 | 5.31 Billion CNY | 16.83% |
| 2016 Q4 | 3.51 Billion CNY | -10.11% |
| 2016 Q3 | 3.9 Billion CNY | -5.74% |
| 2016 Q2 | 4.14 Billion CNY | -0.95% |
| 2016 Q1 | 4.18 Billion CNY | 22.01% |
| 2016 FY | 3.51 Billion CNY | 2.4% |
| 2015 Q3 | 3.47 Billion CNY | 0.0% |
| 2015 Q4 | 3.42 Billion CNY | -1.21% |
| 2015 FY | 3.42 Billion CNY | 3.47% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 FY | 3.31 Billion CNY | 17.28% |
| 2013 FY | 2.82 Billion CNY | 27.03% |
| 2012 FY | 2.22 Billion CNY | 67.49% |
| 2011 FY | 1.32 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 17.12 Billion CNY | 31.116% |
| Yixintang Pharmaceutical Group Co., Ltd. | 16.64 Billion CNY | 29.156% |
| ZJAMP Group Co., Ltd. | 20.31 Billion CNY | 41.942% |
| Ji Yao Holding Group Co., Ltd. | 1.91 Billion CNY | -516.239% |